The American Heart Association recommends eating at least two
servings of fish a week and considering supplements of omega-3 fatty
acids when that’s not possible. Previous research has linked
omega-3s to a lower risk of abnormal heartbeats, less fats in the
blood, reduced risk of artery-clogging deposits known as plaque, and
slightly lower blood pressure.
For the current study, researchers examined data from 10 trials with
a total of 77,917 participants with a previous heart attack or
stroke or health problems like diabetes. Most had been randomly
assigned to take either omega-3 fatty acid supplements or a placebo,
or dummy pill, for at least one year.
Overall, participants were 64 years old on average when they joined
the trials, and they were followed for an average of 4.4 years.
During follow-up, 2,695 people (3.5 percent) died from heart
disease, while 2,276 (2.9 percent) had nonfatal heart attacks, 1,713
(2.2 percent) had strokes and 6,603 (8.5 percent) had procedures to
reopen clogged arteries.
Risks for these outcomes were the same whether or not people took
omega-3 fatty acid supplements, researchers report in JAMA
Cardiology.
“The results . . . demonstrated no beneficial effect of omega-3
fatty acid supplements for prevention of cardiovascular disease,
overall, or on any subtype of cardiovascular disease, or on
cardiovascular disease in any subgroup of the population,” said
senior study author Dr. Robert Clarke, a public health researcher at
the University of Oxford in the UK.
“Thus, the results . . . provide no support for the current
guidelines of the American Heart Association that advocate that
patients with prior coronary heart disease take omega-3 fatty acid
supplements for the prevention of cardiovascular disease,” Clarke
said by email.
Most of the trials in the current study included different doses and
combinations of two omega-3s: EPA (eicosapentaenoic acid) and DHA (docosahexaenoic
acid). Across the trials, people took these supplements for an
average of one to six years.
While taking these supplements appeared tied to a slightly lower
risk of death from heart disease, nonfatal heart attacks, and all
coronary heart disease events, the differences in each case were too
small to rule out the possibility that they were due to chance.
[to top of second column] |
One limitation of the study was the wide variation in study designs
for the randomized trials, the authors note. Another drawback is the
lack of data on smoking status or detailed cancer history for
individual participants, both of which might independently impact
the odds of developing heart disease or dying from it.
Even if there isn’t overwhelming evidence that omega-3 supplements
protect against heart disease, it still may be a reasonable choice
for patients because the supplements are inexpensive and safe with
virtually no serious side effects, said Dr. Carl Lavie, medical
director of the cardiac rehabilitation program and preventive
cardiology at the John Ochsner Heart and Vascular Institute at the
University of Queensland School of Medicine in New Orleans,
Louisiana.
“So the evidence for omega-3 does not have to be nearly at the same
level of expensive and risky medications and devices,” Lavie, who
wasn’t involved in the study, said by email. “The fact is that a lot
of our patients who oppose many therapies are very happy to use
things like omega-3 supplements, and this should not be ignored.”
People already taking omega-3 supplements shouldn’t stop, and there
are other reasons beyond just heart health to consider this option,
said Dr. Dominik Alexander, a researcher at the EpidStat Institute
in Ann Arbor, Michigan, who wasn’t involved in the study.
“In addition to maintaining a healthy body weight, habitually
engaging in physical activity, and not smoking, consumers should
regularly eat fatty fish as part of a well-balanced diet or
supplement their diets with a high quality omega-3 supplement,”
Alexander said by email. “The heart health benefits are well
documented, and there may be other important health benefits as
well, including memory, cognition and eye health.”
SOURCE: http://bit.ly/2BQ4QH2 JAMA Cardiology, online January 31,
2018.
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |